Bile signalling promotes chronic respiratory infections and antibiotic tolerance

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Reen, F Jerry ^a   Flynn, Stephanie ^a   Woods, David F ^a   Dunphy, Niall ^a   Chróinín, Muireann Ní ^b   Mullane, David ^b   Stick, Stephen ^c   Adams, Claire ^a   O'Gara, Fergal ^a,c,d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BILE ACID; CHENODEOXYCHOLIC ACID;

BIOFILM; CELL LINE; CHRONIC DISEASE; COMPLICATION; CYSTIC FIBROSIS; DRUG EFFECT; DRUG TOLERANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SPUTUM;

ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; BIOFILMS; CELL LINE; CHENODEOXYCHOLIC ACID; CHRONIC DISEASE; CYSTIC FIBROSIS; DRUG TOLERANCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SPUTUM;

EID: 84979210515     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29768     Document Type: Article

References (73)

1. Cooper, M. A. & Shlaes, D. Fix the antibiotics pipeline. Nature 472, 32-32, doi: 10.1038/472032a (2011).
2. Dickson, R. P. & Huffnagle, G. B. The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease. PLoS Pathog 11, e1004923, doi: 10.1371/journal.ppat.1004923 (2015).
3. Surette, M. G. The cystic fibrosis lung microbiome. Ann Amer Thorac Soc 11 Suppl 1, S61-S65, doi: 10.1513/AnnalsATS.201306- 159MG (2014).
4. Han, M. K. et al. Significance of the microbiome in obstructive lung disease. Thorax 67, 456-463, doi: 10.1136/thoraxjnl-2011-201183 (2012).
5. Boyton, R. J., Reynolds, C. J., Quigley, K. J. & Altmann, D. M. Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis. Clin Exper Immun 171, 117-123, doi: 10.1111/cei.12003 (2013).
6. Huang, Y. J. & Boushey, H. A. The microbiome in asthma. J Allergy Clin Immun 135, 25-30, doi: 10.1016/j.jaci.2014.11.011 (2015).
7. Aseeri, A. et al. Bile acids are present in the lower airways of people with cystic fibrosis. Am J Respir Crit Care Med 185, 463, doi: 10.1164/ajrccm.185.4.463 (2012).
8. Navarro, J. et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 18, 298-305 (2001).
9. Pauwels, A. et al. Bile Acids in Sputum and Increased Airway Inflammation in Patients with Cystic Fibrosis. Chest, doi: chest.11-1573/chest.11-1573 (2011).
10. Reen, F. J. et al. Aspirated bile: a major host trigger modulating respiratory pathogen colonisation in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 33, 1763-1771, doi: 10.1007/s10096-014-2133-8 (2014).
11. Reen, F. J., Woods, D. F., Mooij, M. J., Adams, C. & O'Gara, F. Respiratory pathogens adopt a chronic lifestyle in response to bile. PLoS One 7, e45978, doi: 10.1371/journal.pone.0045978 (2012).
12. D'Ovidio, F. et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 129, 1144-1152, doi: S002252230401685X/j.jtcvs.2004.10.035 (2005).
13. Legendre, C. et al. Pseudomonas aeruginosa Alkyl quinolones repress hypoxia-inducible factor 1 (HIF-1) signaling through HIF- 1alpha degradation. Infect Immun 80, 3985-3992, doi: 10.1128/IAI.00554-12 (2012).
14. Legendre, C. et al. Bile acids repress hypoxia-inducible factor 1 signaling and modulate the airway immune response. Infect Immun 82, 3531-3541, doi: 10.1128/IAI.00674-13 (2014).
15. Benson, V. S. et al. Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease. Respir Med, doi: 10.1016/j.rmed.2015.06.009 (2015).
16. Blondeau, K. et al. Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 50, 161-166, doi: 10.1097/MPG.0b013e3181acae98 (2010).
17. Calfee, M. W., Coleman, J. P. & Pesci, E. C. Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc Natl Acad Sci USA 98, 11633-11637, doi: 10.1073/pnas.201328498 (2001).
18. Kuang, Z. et al. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS One 6, e27091, doi: 10.1371/journal.pone.0027091 (2011).
19. Atichartpongkul, S., Fuangthong, M., Vattanaviboon, P. & Mongkolsuk, S. Analyses of the regulatory mechanism and physiological roles of Pseudomonas aeruginosa OhrR, a transcription regulator and a sensor of organic hydroperoxides. J Bacteriol 192, 2093-2101, doi: 10.1128/JB.01510-09 (2010).
20. Beaume, M. et al. Metabolic pathways of Pseudomonas aeruginosa involved in competition with respiratory bacterial pathogens. Frontiers Microbiol 6, 321, doi: 10.3389/fmicb.2015.00321 (2015).
21. Chen, H. et al. The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc Natl Acad Sci USA 105, 13586-13591, doi: 10.1073/pnas.0803391105 (2008).
22. Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I. & Hancock, R. E. Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa. J Bacteriol 190, 5624-5634, doi: 10.1128/JB.00594-08 (2008).
23. Heuston, S., Begley, M., Gahan, C. G. & Hill, C. Isoprenoid biosynthesis in bacterial pathogens. Microbiol 158, 1389-1401, doi: 10.1099/mic.0.051599-0 (2012).
24. Sana, T. G., Soscia, C., Tonglet, C. M., Garvis, S. & Bleves, S. Divergent control of two type VI secretion systems by RpoN in Pseudomonas aeruginosa. PLoS One 8, e76030, doi: 10.1371/journal.pone.0076030 (2013).
25. Wargo, M. J. Choline catabolism to glycine betaine contributes to Pseudomonas aeruginosa survival during murine lung infection. PLoS One 8, e56850, doi: 10.1371/journal.pone.0056850 (2013).
26. Palmer, G. C., Palmer, K. L., Jorth, P. A. & Whiteley, M. Characterization of the Pseudomonas aeruginosa transcriptional response to phenylalanine and tyrosine. J Bacteriol 192, 2722-2728, doi: 10.1128/JB.00112-10 (2010).
27. O'Callaghan, J. et al. A novel host responsive sensor mediates virulence and type III secretion during Pseudomonas aeruginosa-host cell interactions. Microbiology, 158 (Pt 4), 1057-1070, doi: mic.0.056127-0/mic.0.056127-0 (2012).
28. Fargier, E. et al. MexT Functions as a Redox-Responsive Regulator Modulating Disulfide Stress Resistance in Pseudomonas aeruginosa. J Bacteriol 194, 3502-3511, doi: 10.1128/Jb.06632-11 (2012).
29. Dalebroux, Z. D., Svensson, S. L., Gaynor, E. C. & Swanson, M. S. ppGpp Conjures Bacterial Virulence. Microbiol Mol Biol R 74, 171? + , doi: 10.1128/Mmbr.00046-09 (2010).
30. Poncet, S. et al. Correlations between Carbon Metabolism and Virulence in Bacteria. Contrib Microbiol 16, 88-102 (2009).
31. Price-Whelan, A., Dietrich, L. E. P. & Newman, D. K. Pyocyanin alters redox Homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. J Bacteriol 189, 6372-6381, doi: 10.1128/Jb.00505-07 (2007).
32. Schoen, C., Kischkies, L., Elias, J. & Ampattu, B. J. Metabolism and virulence in Neisseria meningitidis. Front Cell Infect Mi 4, doi: ARTN 114 10.3389/fcimb.2014.00114 (2014).
33. Somerville, G. A. & Proctor, R. A. At the Crossroads of Bacterial Metabolism and Virulence Factor Synthesis in Staphylococci. Microbiol Mol Biol R 73, 233-248, doi: 10.1128/Mmbr.00005-09 (2009).
34. Dietrich, L. E. P. et al. Bacterial Community Morphogenesis Is Intimately Linked to the Intracellular Redox State. J Bacteriol 195, 1371-1380, doi: 10.1128/Jb.02273-12 (2013).
35. Li, X. Z., Zhang, L. & Poole, K. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemoth 45, 433-436, doi: 10.1093/jac/45.4.433 (2000).
36. Lomovskaya, O. & Lewis, K. Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci USA 89, 8938-8942 (1992).
37. Nowicki, E. M., O'Brien, J. P., Brodbelt, J. S. & Trent, M. S. Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system. Mol Microbiol 97, 166-178, doi: 10.1111/mmi.13018 (2015).
38. Olaitan, A. O., Morand, S. & Rolain, J. M. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Frontiers Microbiol 5, 643, doi: 10.3389/fmicb.2014.00643 (2014).
39. Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis, 16(2), 161-168, doi: 10.1016/S1473-3099(15)00424-7 (2015).
40. Campbell, E. L. et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40, 66-77, doi: 10.1016/j.immuni.2013.11.020 (2014).
41. Noh, K., Kim, Y. M., Kim, Y. W. & Kim, S. G. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/ enhancer binding protein beta. Drug Metab Dispos 39, 1451-1459, doi: 10.1124/dmd.111.038414 (2011).
42. Nomoto, M. et al. Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor. Biol Pharm Bull 32, 172-178 (2009).
43. Fothergill, J. L., Mowat, E., Ledson, M. J., Walshaw, M. J. & Winstanley, C. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. J Med Microbiol 59, 472-481, doi: 10.1099/jmm.0.015875-0 (2010).
44. Varga, J. J. et al. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains. BMC Genomics 16, 883, doi: 10.1186/s12864-015-2069-0 (2015).
45. Jeukens, J. et al. Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients. PLoS One 9, e87611, doi: 10.1371/journal.pone.0087611 (2014).
46. Blainey, P. C., Milla, C. E., Cornfield, D. N. & Quake, S. R. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Trans Med 4, 153ra130, doi: 10.1126/scitranslmed.3004458 (2012).
47. Palmer, G. C. & Whiteley, M. Metabolism and Pathogenicity of Pseudomonas aeruginosa Infections in the Lungs of Individuals with Cystic Fibrosis. Microbiol Spectr 3, doi: 10.1128/microbiolspec.MBP-0003-2014 (2015).
48. Takeuchi, K. et al. Small RNA-dependent expression of secondary metabolism is controlled by Krebs cycle function in Pseudomonas fluorescens. J Biol Chem 284, 34976-34985, doi: 10.1074/jbc.M109.052571 (2009).
49. Tchawa Yimga, M. et al. Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice. Infect Immun 74, 1130-1140, doi: 10.1128/IAI.74.2.1130-1140.2006 (2006).
50. Reniere, M. L. et al. Glutathione activates virulence gene expression of an intracellular pathogen. Nature 517, 170-173, doi: 10.1038/ nature14029 (2015).
51. Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbe, A. & Prakash, S. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther 14, 467-482, doi: 10.1517/14712598.2014.880420 (2014).
52. Ladel, C. H. et al. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65, 4843-4849 (1997).
53. Sutherland, R. E., Olsen, J. S., McKinstry, A., Villalta, S. A. & Wolters, P. J. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 181, 5598-5605 (2008).
54. Dalrymple, S. A. et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 63, 2262-2268 (1995).
55. Langan, K. M., Kotsimbos, T. & Peleg, A. Y. Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis. Curr Opin Infect Dis 28, 547-556, doi: 10.1097/QCO.0000000000000217 (2015).
56. Cummins, J., Reen, F. J., Baysse, C., Mooij, M. J. & O'Gara, F. Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. Microbiol 155, 2826-2837, doi: mic.0.025643-0/ mic.0.025643-0 (2009).
57. O'Toole, G. A. & Stewart, P. S. Biofilms strike back. Nat Biotechnol 23, 1378-1379, doi: 10.1038/nbt1105-1378 (2005).
58. Clark, S. T. et al. Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci Rep-Uk 5, doi: ARTN 10932 10.1038/srep10932 (2015).
59. Cullen, L. et al. Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains. Microbiol 161, 1961-1977, doi: 10.1099/mic.0.000155 (2015).
60. Hansen, S. K. et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 6, 31-45, doi: 10.1038/ismej.2011.83 (2012).
61. Sanchez, L. M. et al. Biofilm Formation and Detachment in Gram-Negative Pathogens Is Modulated by Select Bile Acids. PLoS One 11, e0149603, doi: 10.1371/journal.pone.0149603 (2016).
62. Filkins, L. M. & O'Toole, G. A. Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat. PLoS Pathog 11, e1005258, doi: 10.1371/journal.ppat.1005258 (2015).
63. Frydenlund Michelsen, C. et al. Evolution of metabolic divergence in Pseudomonas aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction. ISME J, doi: 10.1038/ismej.2015.220 (2015).
64. Casadevall, A. The case for pathogen-specific therapy. Expert Opin Pharmacother 10, 1699-1703, doi: 10.1517/14656560903066837 (2009).
65. Harmer, C. J. et al. Homogentisate 1-2-Dioxygenase Downregulation in the Chronic Persistence of Pseudomonas aeruginosa Australian Epidemic Strain-1 in the CF Lung. PLoS One 10, e0134229, doi: 10.1371/journal.pone.0134229 (2015).
66. Sheikh, S. I., Ryan-Wenger, N. A. & McCoy, K. S. Outcomes of surgical management of severe GERD in patients with cystic fibrosis. Pediatr Pulmonol 48, 556-562, doi: 10.1002/ppul.22630 (2013).
67. Boesch, R. P. & Acton, J. D. Outcomes of fundoplication in children with cystic fibrosis. J Pediatr Surg 42, 1341-1344, doi: 10.1016/j. jpedsurg.2007.03.030 (2007).
68. Wakeman, D. S., Wilson, N. A. & Warner, B. W. Current status of surgical management of gastroesophageal reflux in children. Curr Opin Pediatr 28, 356-362, doi: 10.1097/MOP.0000000000000341 (2016).
69. Hawkyard, C. V. & Koerner, R. J. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks - Response. J Antimicrob Chemoth 61, 227-228, doi: 10.1093/jac/dkm451 (2008).
70. Liberati, N. T. et al. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci USA 103, 2833-2838, doi: 0511100103/pnas.0511100103 (2006).
71. Pearson, J. P., Pesci, E. C. & Iglewski, B. H. Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes. J Bacteriol 179, 5756-5767 (1997).
72. Ghafoor, A., Hay, I. D. & Rehm, B. H. A. Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture. Appl Environ Microb 77, 5238-5246, doi: 10.1128/AEM.00637-11 (2011).
73. Tachon, S. et al. Experimental conditions affect the site of tetrazolium violet reduction in the electron transport chain of Lactococcus lactis. Microbiol 155, 2941-2948, doi: 10.1099/mic.0.029678-0 (2009).